The Valley Desk

Clinical trial reportClinical cancer research : an official journal of the American Association for Cancer ResearchPublished

First-in-Human Clinical Trial of a Small-Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr-Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic Studies

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names The Wistar Institute. Affiliation source

Publication record

Type
Clinical trial report
Venue
Clinical cancer research : an official journal of the American Association for Cancer Research
Published
Subject terms
Humans; Herpesvirus 4, Human; Epstein-Barr Virus Infections; Nasopharyngeal Neoplasms; DNA, Viral; Epstein-Barr Virus Nuclear Antigens; Adult; Aged; Middle Aged; Female; Male; Nasopharyngeal Carcinoma
PubMed ID
39831818
PubMed Central ID
PMC11915201
Added to directory
Source checked

Report a correction or request removal